Manufacturer: R&D Systems
Pack Size | SKU | Availability | Price |
---|---|---|---|
Each of 1 | MAB229-Each-of-1 | In Stock | ₹ 59,164.74 |
MAB229 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 59,164.74
GST (18%): ₹ 10,649.653
Total Price: ₹ 69,814.393
CD30/TNFRSF8
Monoclonal
Unconjugated
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Mouse
Protein A or G purified from ascites
RUO
Primary
Detects human CD30/TNFRSF8 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant mouse CD30, recombinant human (rh) CD27, and rhCD40 is observed.
Human
Purified
Western Blot, Flow Cytometry, CyTOF
81337
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Agonist Activity 0.05-0.2 ug/mL, CyTOF-ready
P28908
TNFRSF8
S. frugiperdainsect ovarian cell lineSf21-derived recombinant human CD30/TNFRSF8 Phe19-Lys379 Accession # P28908
500 μg
Agonist Activity
943
Reconstitute at 0.5 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
IgG2b